Texas Yale Capital Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,808
| Closed | -$262K | – | 462 |
|
|
2022
Q2 | $262K | Buy |
4,808
+184
| +4% | +$10K | 0.02% | 379 |
|
|
2022
Q1 | $252K | Buy |
4,624
+376
| +9% | +$20.5K | 0.01% | 398 |
|
|
2021
Q4 | $234K | Buy |
4,248
+56
| +1% | +$3.09K | 0.01% | 411 |
|
|
2021
Q3 | $200K | Buy |
+4,192
| New | +$200K | 0.01% | 431 |
|
|
2017
Q4 | – | Sell |
-7,398
| Closed | -$375K | – | 443 |
|
|
2017
Q3 | $375K | Buy |
7,398
+238
| +3% | +$12.1K | 0.03% | 353 |
|
|
2017
Q2 | $386K | Hold |
7,160
| – | – | 0.03% | 344 |
|
|
2017
Q1 | $377K | Hold |
7,160
| – | – | 0.03% | 345 |
|
|
2016
Q4 | $345K | Sell |
7,160
-7,720
| -52% | -$372K | 0.03% | 350 |
|
|
2016
Q3 | $802K | Sell |
14,880
-4,000
| -21% | -$216K | 0.08% | 232 |
|
|
2016
Q2 | $1.02M | Buy |
18,880
+8,560
| +83% | +$464K | 0.1% | 184 |
|
|
2016
Q1 | $523K | Hold |
10,320
| – | – | 0.05% | 287 |
|
|
2015
Q4 | $521K | Hold |
10,320
| – | – | 0.05% | 286 |
|
|
2015
Q3 | $496K | Buy |
10,320
+1,840
| +22% | +$88.4K | 0.05% | 303 |
|
|
2015
Q2 | $441K | Buy |
8,480
+4,000
| +89% | +$208K | 0.04% | 357 |
|
|
2015
Q1 | $258K | Hold |
4,480
| – | – | 0.02% | 429 |
|
|
2014
Q4 | $239K | Hold |
4,480
| – | – | 0.02% | 427 |
|
|
2014
Q3 | $257K | Hold |
4,480
| – | – | 0.02% | 387 |
|
|
2014
Q2 | $299K | Buy |
4,480
+240
| +6% | +$16K | 0.04% | 314 |
|
|
2014
Q1 | $283K | Hold |
4,240
| – | – | 0.04% | 306 |
|
|
2013
Q4 | $283K | Hold |
4,240
| – | – | 0.04% | 253 |
|
|
2013
Q3 | $266K | Hold |
4,240
| – | – | 0.04% | 257 |
|
|
2013
Q2 | $265K | Buy |
+4,240
| New | +$265K | 0.05% | 236 |
|